A new CIN Risk Calculator App is now available through the Apple and Android App Stores. Published by RenalGuard Solutions, this app is an easy-to-use clinical tool intended for use by healthcare professionals to help predict the risk of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI).
Android: https://play.google.com/store/apps/details?id=com.renalguard
Apple/IOS: https://itunes.apple.com/us/app/cin-risk-score-calculator